Medication reference
Amphotericin B lipid complex (Abelcet)
Monograph awaiting updateThis monograph will be updated in the future.
Historical source. Current clinical review is incomplete. This monograph will be updated in the future.
Ampho B Lipid Complex (abelcet®) (opens in a new tab)Original source URL: https://globalrph.com/dilution/amphotericin-b-lipid-complex-abelcet/ | Retrieved 2026-11-04
Source dates, location and integrity
This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.
- Original source URL
- https://globalrph.com/dilution/amphotericin-b-lipid-complex-abelcet/ (opens in a new tab)
- Source date
- Not established in the retrieved source
- Retrieved
- 2026-11-04T19:45:54.165308+00:00
- Source location
- div.post-content
- Packaged content SHA-256
- 7d7c16558146d29b3ea1c2bba29bc488a807864879435a927318ab339a16e9d5
- Original response SHA-256
- f30cccd4608809fd975becbc03960854c64883fc9bf264ccd9298a2d6990cd70
- Source body SHA-256
- 46a411c9ffd74976135e900489d1a9b11ce3333b266208c58d1038907c423673
AMPHOTERICIN B LIPID COMPLEX (ABELCET ®) |
| The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. |
Usual Diluents |
| D5W |
Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate] |
| ---Concentration 1 mg/ml--- [300 mg/ 240 ml] [2 hours] [350 mg/280 ml] [2 hours] [400 mg/ 320 ml] [2 hours] Minimum dilution: |
Stability / Miscellaneous |
| Indications: treatment of aspergillosis in patients who are refractory to or intolerant of conventional ampho-B therapy.
DOSAGE AND ADMINISTRATION Renal toxicity of ABELCET®, as measured by serum creatinine levels, has been shown to be dose dependent. Decisions about dose adjustments should be made only after taking into account the overall clinical condition of the patient. Preparation of Admixture for Infusion DO NOT DILUTE WITH SALINE SOLUTIONS OR MIX WITH OTHER DRUGS OR ELECTROLYTES as the compatibility of ABELCET® with these materials has not been established. An existing intravenous line should be flushed with 5% Dextrose Injection before infusion of ABELCET®, or a separate infusion line should be used. DO NOT USE AN IN-LINE FILTER. Stability: HOW SUPPLIED STORAGE The admixed ABELCET® and 5% Dextrose Injection may be stored for up to 48 hours at 2° to 8°C (36° to 46°F) and an additional 6 hours at room temperature. Do not freeze. Any unused material should be discarded. |
Product identifiers and clinical review status
This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.
Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.
What remains to be completed
- Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
- Clinically reviewed, individually identified statements with two exact source mappings
- Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
- Renal-function methods and dialysis/CRRT modality review where applicable
- Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation
Supplemental historical fields
Restored-data provenance and review notes
Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.
Current review annotations for historical renal, dialysis, mechanism, and product fields
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Renal
- Status
- not_locally_normalized
- Original classification
- monitor_or_titrate
- Entries
- General note
- Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
- Dialysis
- Status
- no_local_structured_regimen
- Entries
- General note
- Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
- Mechanisms
- Source kind
- first_look
- Local pointer
- /mechanism
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- Not recorded
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Source kind
- label_snapshot
- Local pointer
- /mechanism_summary
- Original level
- drug_specific
- Provenance classification
- historical_drug_specific_uncorroborated
- Label derived verified
- false
- Independently corroborated
- false
- Exact label section
- Not recorded
- Original source note
- GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
- Review status
- historical_unverified
- Note
- Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
- Future update
- Status
- pending_review
- Message
- This monograph will be updated in the future as current exact-product and claim-level review is completed.
- Source unavailable
- false
- Reason
- The historical content is restored; comprehensive contemporary verification remains incomplete.
Historical first look: uses, mechanism, dosing context, and administration
Recovered v5.1 source content; historical, awaiting current review.
- Id
- amphotericin-b-lipid-complex-abelcet
Source ID
H51-EC12E0680A64DB8540BDCAC9 - Generic name
- Amphotericin B lipid complex (Abelcet)
Source ID
H51-F87102A775E7537EF87C9CF2 - Class
- Antifungal
Source ID
H51-F77D1FED80912ABA84C56459 - Subclass
- Legacy GlobalRPh directory entry
Source ID
H51-9919CC0EA6063D1DAE087B3F - Primary uses
- Severe or invasive fungal infection when the organism, site, patient factors, and current labeling support IV therapy.
Source ID
H51-6857F1B01FEA9C9CEA158A72
- Severe or invasive fungal infection when the organism, site, patient factors, and current labeling support IV therapy.
- Mechanism
- Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents.
Source ID
H51-CE9F8A74E007CD5AF805CA2D - Mechanism level
- drug_specific
Source ID
H51-0CC0CA1C5F1B6BE23DB83351 - Basic dosing orientation
- Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary.
Source ID
H51-9847926636C3185EA09D4323 - Administration orientation
- Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion.
Source ID
H51-D97CA7E125DFB6319EF3FB34 - Renal and population orientation
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
Source ID
H51-8E4DF0E688EB36684E6A0BF5 - Key safety orientation
- Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable.
Source ID
H51-EA2F8ACB7000E281FFD4B611 - Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-CFBA4FD877830AD2C31B7C43
- Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable.
- Coverage path
- reviewed_local_label_summary
Source ID
H51-83A235DA6F1B55D1CCD1E06B - Coverage path label
- Reviewed local package-insert summary
Source ID
H51-DBB217CD959407724F005DDB - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-9A4D85364610E6AC52F637B9 - Legacy title
- Amphotericin B lipid complex (Abelcet)
Source ID
H51-6111A58C3594140A080CA215 - Review note
- First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
Source ID
H51-E030FCB780DDE2766ADA0144 - Search text
- Amphotericin B lipid complex (Abelcet) Antifungal Legacy GlobalRPh directory entry Severe or invasive fungal infection when the organism, site, patient factors, and current labeling support IV therapy. Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents. Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary. Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion. Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply. Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable. Legacy content must be reconciled against current labeling and institutional policy before clinical use. Reviewed local package-insert summary
Source ID
H51-35992005BFC3BB6CD69FC247 - Official access mode
- direct_label
Source ID
H51-2A697EDC5813C054384B70E2 - Official access url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-FA66CF6357944B58262F6C80 - Official access reason
- A source-specific DailyMed label route is available.
Source ID
H51-CF2EB4B0508B9BE1E00D0C35 - Label snapshot available
- true
Source ID
H51-2D87ED9E25C969EB38FC78DB - Label snapshot setid
- 5587db37-f21a-4a39-a319-e1077032ced9
Source ID
H51-380473B09C3B8F7B8E7232E0
No separate structured rows were bundled for preparation, IV push, continuous infusion, population dosing, dialysis, CRRT. Historical article content and source links may cover these topics.
Historical local label preparation summary
Recovered v5.1 source content; historical, awaiting current review.
- Id
- abelcet
Source ID
H51-90248A6292A9AD095EA243D7 - Match names
- Amphotericin B lipid complex
Source ID
H51-5CA2B43CB1C41358095CF7D5 - Abelcet
Source ID
H51-58CEA27E588461D820CB9A0F
- Amphotericin B lipid complex
- Label title
- Amphotericin B lipid complex injection (Abelcet)
Source ID
H51-3BC888FB031D391F5CAB4677 - Brand names
- Abelcet
Source ID
H51-BB6F56BD85BF29A8873E7943
- Abelcet
- Formulation
- Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
Source ID
H51-12677563805B9A097FB88260 - Reconstitution
- No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure.
Source ID
H51-064A1D577873392903450EA6 - Stock concentration
- 5 mg/mL.
Source ID
H51-733583780B706FE7C18B7D7E - Diluents
- Dilute in 5% dextrose injection. Do not dilute with saline or mix with other drugs.
Source ID
H51-7001AA978E7CB27B30015602 - Final concentration
- 1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL.
Source ID
H51-399A5734521A2E98875C6DE4 - Containers
- Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations.
Source ID
H51-0D1BC155561766A66CC80DC6 - Infusion time
- Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
Source ID
H51-69AD63C46B2E1007B4086E47 - Fluid restriction
- The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval.
Source ID
H51-04FD3C1E2934902703FF2C3F - Stability
- The diluted admixture may be stored for up to 48 hours at 2 to 8 C and then for an additional 6 hours at room temperature. Do not freeze and discard unused material.
Source ID
H51-52600D3F3B6D1673325B337B - Line filter
- Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion.
Source ID
H51-BA22986FFAF1E62F0A4CE723 - Adult applicability
- Adult dosing is weight based and indication specific.
Source ID
H51-FB9B19480AE04DFADEB387E9 - Pediatric applicability
- The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
Source ID
H51-46BF988569EE626256CE46F1 - Neonatal applicability
- Neonatal dosing is not generated from the adult preparation summary.
Source ID
H51-CBF4CBA0023B3E2BCF7C8A2E - Renal dialysis
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions.
Source ID
H51-62FB863182723CF6C81D34AF - Key warnings
- Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable.
Source ID
H51-85DFD2094142724598601013 - Catalog id
- amphotericin-b-lipid-complex-abelcet
Source ID
H51-9999F97D41BAC263F8055E36 - Catalog name
- Amphotericin B lipid complex (Abelcet)
Source ID
H51-BCE18EE1FEF1D717F07E7038 - Review date
- 2026-08-30
Source ID
H51-FDE4B5FDA5DE0553E872040D - Source type
- Reviewed local summary derived from an archived official DailyMed label; current product availability and exact marketed formulation must be confirmed before use.
Source ID
H51-3A2D514FD790F9181F335C3C - Official link type
- DailyMed official label
Source ID
H51-C861DAECC03A91C8F0F7030F - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-97D56550D4D0D67D812B041B - Official search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=ABELCET+amphotericin+B+lipid+complex+injection (opens in a new tab)
Source ID
H51-E22A3B8AFEF5EAC6E3BF47C8 - Search text
- Amphotericin B lipid complex Abelcet Abelcet abelcet amphotericin-b-lipid-complex-abelcet Amphotericin B lipid complex (Abelcet) Amphotericin B lipid complex injection (Abelcet) Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg). No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure. 5 mg/mL. Dilute in 5% dextrose injection. Do not dilute with saline or mix with other drugs. 1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL. Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations. Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push. The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval. The diluted admixture may be stored for up to 48 hours at 2 to 8 C and then for an additional 6 hours at room temperature. Do not freeze and discard unused material. Withdraw through the supplied 5-micron filter needle; each filter needle may filter up to four 100 mg vials. Flush an existing line with D5W or use a separate line. Do not use an in-line filter during infusion. Adult dosing is weight based and indication specific. The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients. Neonatal dosing is not generated from the adult preparation summary. Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions. Archived-label status: confirm current U.S. product availability before use. Verify Abelcet versus AmBisome versus conventional amphotericin B before preparing the dose; these formulations are not interchangeable. Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review. Reviewed local summary derived from an archived official DailyMed label; current product availability and exact marketed formulation must be confirmed before use. DailyMed official label 2026-08-30
Source ID
H51-9549858FF025276B52D34355 - Label status
- Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review.
Source ID
H51-859C06F2F9323385339E3361 - Label status level
- archived
Source ID
H51-D80B1A520EB8A6BA425C61EF
Historical DailyMed label snapshot
Recovered v5.1 source content; historical, awaiting current review.
- Id
- amphotericin-b-lipid-complex-abelcet
Source ID
H51-36C7059C1CC88CAB18788E10 - Catalog name
- Amphotericin B lipid complex (Abelcet)
Source ID
H51-660FE994704DFA059782A09D - Selection status
- accepted_high_confidence
Source ID
H51-61D6F7C0BCB55A36C469E4C7 - Confidence
- very_high
Source ID
H51-470506A5AEBDCE246A659EBB - Match path
- existing_reviewed_summary
Source ID
H51-58D717A9C68C3956EAC9B80B - Brand name
- Abelcet
Source ID
H51-0448C0A33BF6AA547293D990 - Label title
- Amphotericin B lipid complex injection (Abelcet)
Source ID
H51-79DB2FF48DC30868DF1917A3 - Setid
- 5587db37-f21a-4a39-a319-e1077032ced9
Source ID
H51-7C3020214D2E607CD185285B - Official label url
- https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-A6C8E0443A4D7BF8E5316D9C - Reviewed on
- 2026-08-31
Source ID
H51-489A1744006AEC16FC6EFA70 - Route
- Intravenous; see the selected product label for exact route and administration method.
Source ID
H51-90174E98ACA033969F39EBCA - Dosage form
- Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
Source ID
H51-EEA76F086E65BB2032FE951F - Dosage administration summary
- Separate renal reference: Open Renal Dosing Master (opens in a new tab)
- Adult dosing is weight based and indication specific.
Source ID
H51-9382DD1DBDBD9B8C1334ECF7 - The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
Source ID
H51-1791DAF86AA1389C92C78CF6 - Neonatal dosing is not generated from the adult preparation summary.
Source ID
H51-CEAAAFD78166F34B1DEE5824 - No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure.
Source ID
H51-313971DC5B7ADE709F8CD458 - Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
Source ID
H51-CA01410A822A265D4C506B08 - Monitor renal function, electrolytes, liver tests, blood counts, and infusion reactions.
Source ID
H51-CFCCF441CB3DF026955FFA92
- Adult dosing is weight based and indication specific.
- Dosage forms strengths
- Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
Source ID
H51-0FA49A5271C1BAEFF1775CBF - 5 mg/mL.
Source ID
H51-75A1EC4458EA803B99AE544B
- Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
- Mechanism summary
- Binds fungal membrane ergosterol, forms pores, and causes leakage of intracellular contents.
Source ID
H51-275AF18A73DA1322333B0765 - Mechanism source
- GlobalRPh drug-specific mechanism summary retained alongside the selected DailyMed label.
Source ID
H51-7BF06C49AC7965299FA8338B - Scope note
- The locally reviewed preparation summary remains the primary product-specific preparation snapshot. This broader label snapshot is concise and does not reproduce the full prescribing information.
Source ID
H51-371795E482F52C18FA20876C - Source sections
- Dosage and Administration
Source ID
H51-BA8475592B9CE53FC1D566CF - Dosage Forms and Strengths
Source ID
H51-A56EA815A14BD04C06A40DE8 - Clinical Pharmacology or Microbiology as applicable
Source ID
H51-202D5E53CD010D386570FA99
- Dosage and Administration
- Retrieval method
- Manual build-time review of the current DailyMed full prescribing information for the selected Set ID; no live server retrieval is required during page use.
Source ID
H51-CD26F57513702D05EDA2765C - Label status
- archived
Source ID
H51-227E3ACC81CD541B42FD54C3 - Disclaimer
- Verify the exact formulation, strength, manufacturer, NDC, route, current label revision, patient-specific order, institutional policy, and monitoring before use.
Source ID
H51-ED7F68A86334C1347584B6B4
Historical renal-function guidance
Recovered v5.1 source content; historical, awaiting current review.
Separate renal reference: Open Renal Dosing Master (opens in a new tab)- Classification
- monitor_or_titrate
Source ID
H51-BA288D116B89668079C12C6D - Summary
- Renal function materially affects toxicity, monitoring, or titration even when a fixed table may not apply.
Source ID
H51-541A534939A90E4CBE233840 - Method note
- Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
Source ID
H51-3BEAFF7675A9268F076ADF30
Historical Warnings and safeguards
Recovered v5.1 source content; historical, awaiting current review.
- Legacy content must be reconciled against current labeling and institutional policy before clinical use.
Source ID
H51-8A2011802254756741ACC57E
Historical Stability notes
Recovered v5.1 source content; historical, awaiting current review.
- Legacy product stability information is not automatically equivalent to a USP <797> BUD.
Source ID
H51-2E6A75FF0E0129FA43B60885
Historical supplemental professional sources
Recovered v5.1 source content; historical, awaiting current review.
| Label | Url | Kind |
|---|---|---|
Source IDH51-BB4512AACAC33D1B36A7488FSource IDH51-F470DAF97BB2C59AAE7C8027 | https://idmp.ucsf.edu/adult-antimicrobial-dosing-non-dialysis (opens in a new tab)Source IDH51-AB8F569DD875F4BE29575673 | Professional institutional guidanceSource IDH51-C813C01C303F2CE8ECCDD74E |
Source IDH51-F795337BE666F79CC50853BBSource IDH51-F8D31534ABBB9D194D8D5A00 | https://idmp.ucsf.edu/antimicrobial-dosing-intermittent-continuous-hemodialysis (opens in a new tab)Source IDH51-554D6A9E626342DEC343E8ED | Professional institutional guidanceSource IDH51-A483C245D6C9DEC6E5EF2C75 |
Source IDH51-0FF83EF5BE642D5FE121F928Source IDH51-F29DF5FE91F574E3B9BC4F57 | https://idmp.ucsf.edu/pediatric-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-4DF150CFD92D8FB64673B70C | Professional institutional guidanceSource IDH51-3A9FAF53E89187D852EDB077 |
Source IDH51-ABF029FD2D271514E5ECBC8CSource IDH51-9F236747570C431CBB2421C9 | https://idmp.ucsf.edu/neonatal-antimicrobial-dosing-benioff-childrens-hospitals (opens in a new tab)Source IDH51-72E559D39E403B81D08C58B8 | Professional institutional guidanceSource IDH51-15D697BF8F688799DB68FCA3 |
Other recovered source fields and original editorial metadata
Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.
Catalog source fields
Id
amphotericin-b-lipid-complex-abelcetSource ID
H51-A7FB1A4E7E7C3F99809C25D8Legacy title
Amphotericin B lipid complex (Abelcet)Source ID
H51-92CF55DCCBBDE95194AD41B8Generic name
Amphotericin B lipid complex (Abelcet)Source ID
H51-A8F876D24A7E2439DF6B8409Class
AntifungalSource ID
H51-3B96CBBB60B7818E2A6B9829Subclass
Legacy GlobalRPh directory entrySource ID
H51-7ECB8B9D4F3BC65B90341C44Summary
Existing GlobalRPh IV dilution monograph retained for migration into the unified reference.Source ID
H51-F298361D1D933A1BA830A704Populations
- Population not yet normalized
Source ID
H51-E8F570B625C34AC7DBD5FC27
Evidence tier
Reviewed archived label summary - current availability not confirmedSource ID
H51-82D82F4D054B6662F7E37103High alert
falseSource ID
H51-21DCE240EACBDB25652CD0C5Hazardous
falseSource ID
H51-AD90EE3195AA202AD810A881Status
Legacy migrationSource ID
H51-10511BE5646C802F13AEF959Reviewed
2026-08-30Source ID
H51-924D01E2CAA4B9800B564CC8Version added
LegacySource ID
H51-6FA2D0BDC3960BCC57A81275Sources
| Label | Url | Kind |
|---|---|---|
Source IDH51-C64411F1B653FA57D67D499ESource IDH51-D0F03061427545360F00DB73 | legacy:autoSource IDH51-E1268AFE337858AF4F6072B3 | LegacySource IDH51-8F6B99AA92D0810646075F39 |
Clinical release verification
- Audit version
- 3.4
Source ID
H51-54C140C32017397F1A5FFAB9 - Audited on
- 2026-08-30
Source ID
H51-2C8AFA59064D518FB000DBB7 - Level
- amber
Source ID
H51-0E02DA1B0B662F91E25E5932 - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-2DF99DD9DC3792BA2E4133FA - Exact current label candidate
- false
Source ID
H51-7C4AAFF9F0F365877E19C60F - Reference url count
- 4
Source ID
H51-EFBBE5D46BCE0D40B1F6AFEC - Broken reference count
- 0
Source ID
H51-ACA1643304109FDB0617E861 - Point of use confirmation required
- true
Source ID
H51-1E210F495164AC40ABB75926 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-D3F58E3F19074A808E11413C - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Amphotericin%20B%20lipid%20complex%20%28Abelcet%29 (opens in a new tab)
Source ID
H51-F22E56369FF9D19C49A0AD0E
Version updated
3.8Source ID
H51-2ABCD5B81CE7B77CD5253DC3Dosing source fields
Id
amphotericin-b-lipid-complex-abelcetSource ID
H51-90B0768AB01DF3129F249DCBGeneric name
Amphotericin B lipid complex (Abelcet)Source ID
H51-E63FEEAC5D81ED8D3EF92C78Coverage status
direct_official_label_access_plus_legacy_referenceSource ID
H51-E9FAC943136742538DE3CF9APackage insert
- Query name
- Amphotericin B lipid complex
Source ID
H51-7C53850F5D6A9D9A54F7CA77 - Product and route must match
- true
Source ID
H51-A402DE3B3D0F807ECB72F1AB - Live current label enabled
- false
Source ID
H51-C99A2879AC5751D9F48FB4E0 - Source priority
- Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
Source ID
H51-00F8270F436E92E281CD30BF - Direct official label access enabled
- true
Source ID
H51-063246BF795D202C262106C5 - Outbound server request required
- false
Source ID
H51-A2331F5A062F402245BD9ADB - Local summary status
- archived_reviewed_summary
Source ID
H51-9556CE018D0129933FE69B91
Clinical review
- Locally normalized
- false
Source ID
H51-C852F87A9B9EEDA168C2DE8B - Reviewed
- 2026-08-29
Source ID
H51-DFBDD2DDB0439F82A8B0D67F - Status
- Direct official package-insert access enabled; indication-specific local normalization pending.
Source ID
H51-170AE8C618ECE976ED18C3BA
Clinical release verification
- Audit version
- 3.4
Source ID
H51-6EC9156178F970379343490A - Audited on
- 2026-08-30
Source ID
H51-CB8306F70376F58BF1101B39 - Level
- amber
Source ID
H51-3ECF328D9587B1AC79E9C75A - Release gate
- trusted_professional_source_present_exact_label_unconfirmed
Source ID
H51-BFD39781747ACC8425308773 - Exact current label candidate
- false
Source ID
H51-EAA8D51BA11D6CD788C561E5 - Reference url count
- 4
Source ID
H51-F7C34D40C84F3DF25ED287C3 - Broken reference count
- 0
Source ID
H51-FED687ABAD70FDD259E229BE - Point of use confirmation required
- true
Source ID
H51-986936927E7B0515AC189528 - Note
- Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
Source ID
H51-02AA55024F1D33B6CA5D1762 - Dailymed search url
- https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Amphotericin%20B%20lipid%20complex%20%28Abelcet%29 (opens in a new tab)
Source ID
H51-84A179D07C05629730A877FE
Historical preparation assessment
Recovered v5.1 source content; historical, awaiting current review.
- Id
- amphotericin-b-lipid-complex-abelcet
Source ID
H51-28C966B299ECED4751EE739E - Name
- Amphotericin B lipid complex (Abelcet)
Source ID
H51-F6E957399907A7684A73DFDB - Therapeutic class
- Antifungal
Source ID
H51-DF30314E33922F5701AE7B5F - Review version
- 3.8
Source ID
H51-98AAE8291BF8854E3A35CDF7 - Review date
- 2026-08-30
Source ID
H51-0C630DCBDBB58EA83384D948 - Release status
- reviewed_archived_label_summary_marketing_status_review_required
Source ID
H51-800E0DF2777E30356D93EAEF - Market status
- Status
- archived_label_marketing_end_date_listed
Source ID
H51-E5E2C967DC4B8940AB0D69DE - Basis
- Archived official DailyMed label. The listed NDC and NDA show a marketing end date of August 31, 2025; current U.S. commercial availability was not confirmed during the 2026-08-30 review.
Source ID
H51-5E7C23B2D62BFBF406FD0442
- Ten point assessment
- Exact formulation
- Ready-to-dilute lipid-complex suspension, commonly 5 mg/mL in a 20 mL vial (100 mg).
Source ID
H51-78E5B557E28CF6A2657F2B9A - Reconstitution concentration
- No powder reconstitution is required. Gently mix the suspension and withdraw using the product-specified filtration or withdrawal procedure. 5 mg/mL.
Source ID
H51-18353ADAEE276C2A4E2A26A7 - Maximum or recommended final concentration
- 1 mg/mL is the usual labeled final concentration. For pediatric patients and patients with cardiovascular disease, the label permits dilution in D5W to 2 mg/mL.
Source ID
H51-B410DAF3B6F8E46DF82BEE97 - Appropriate standardized containers
- Use a D5W container sized to produce 1 mg/mL, or 2 mg/mL only for the label-supported pediatric or cardiovascular populations.
Source ID
H51-D0D591D5F1878AE720F66AD8 - Adult dosing range
- Adult dosing is weight based and indication specific.
Source ID
H51-244168F7ABAC1877C9E604D8 - Pediatric dosing range
- The labeled daily dose is weight based for adults and children. A 2 mg/mL final concentration is label supported for pediatric patients.
Source ID
H51-447D68890C90A05B7F6A3D42 - Neonatal dosing range
- Neonatal dosing is not generated from the adult preparation summary.
Source ID
H51-329499090578E391383E8CDA - Infusion time
- Infuse at the label-specified rate, commonly 2.5 mg/kg/hour. Do not administer as IV push.
Source ID
H51-9F1AA15BBB13BD6BD55D082D - Fluid restriction alternatives
- The label-supported 2 mg/mL alternative is limited to pediatric patients and patients with cardiovascular disease. Do not create other concentrated preparations without exact-product and institutional approval.
Source ID
H51-4686AC7D68EFBD5DBF457953 - Current manufacturer labeling
- Setid
- 5587db37-f21a-4a39-a319-e1077032ced9
Source ID
H51-65C68AE7EBEFA90FC131DEE1 - Title
- Amphotericin B lipid complex injection (Abelcet)
Source ID
H51-AA93C56DB61C6865198B332A - Routes
- INTRAVENOUS
Source ID
H51-4BB4F979C30F9256FDF10A15
- INTRAVENOUS
- Match confidence
- reviewed_archived_label
Source ID
H51-774B4857B44ECAE94B147AA5 - Url
- https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-47A964FF7189EC8EDA07B95C
- Field provenance
- Exact formulation
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-571BF02A3A1E6F39D82FDA5E
- Reconstitution concentration
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-C75D6849FF2D6B892DEC6C4C
- Maximum or recommended final concentration
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-7DC9D212C1DDEA51065BC172
- Appropriate standardized containers
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-CD8B8A75BD78EF97D32FA9F5
- Adult dosing range
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-0BB7C61441407B4D12050CC7
- Pediatric dosing range
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-C4CF55AEF7424D98F3930BC6
- Neonatal dosing range
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-B5E9BF5576A6B5267CD2A8F1
- Infusion time
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-2C4DABDD92C4995D6512809E
- Fluid restriction alternatives
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-D1D8882A7163FC633E0A421B
- Current manufacturer labeling
- Primary
- official_dailymed_archived_label_summary
Source ID
H51-C94FC58AD7C9F5C69377F789
- Population applicability
- Adult
- Applicability
- supported_or_source_present
Source ID
H51-9D4C67D48C35B2FE994B805C - Guide generation allowed
- false
Source ID
H51-48656EE0CB706D2703B3F42D
- Pediatric
- Applicability
- supported_or_source_present
Source ID
H51-4C0674C5277041B23DE7EA63 - Guide generation allowed
- false
Source ID
H51-0B10EFF60972A53FB1DA3B51
- Neonatal
- Applicability
- not_established_or_requires_separate_guidance
Source ID
H51-27438BFBDD5CD4134EABC4CA - Guide generation allowed
- false
Source ID
H51-00B803499CB4ECB38365E93B
- Route presence
- Structured dilution
- false
Source ID
H51-43096ED84E98E2B5DCD858C2 - Iv push
- false
Source ID
H51-6C5E4782EAD242D415A6D2F5 - Continuous infusion
- true
Source ID
H51-847E25C731ADE5C700F29895 - Pediatric source
- true
Source ID
H51-692FC63755C74B55AED3F9F2 - Neonatal source
- true
Source ID
H51-D484101240D2D6F65F4FFD24
- Legacy reference
- Status
- not_available
Source ID
H51-20483F0583EFF0A0A2BC7754
- Label resolution
- Status
- reviewed_archived_official_label
Source ID
H51-C5F654FEDD852FAD9592118B - Existing setids
- 5587db37-f21a-4a39-a319-e1077032ced9
Source ID
H51-7F18C8B1D640D2AC61073294
- 5587db37-f21a-4a39-a319-e1077032ced9
- Official url
- https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-7EBF9B38D3C93B2892B70EBF - Review date
- 2026-08-30
Source ID
H51-CF969872D661050E5AAA3D90
- Source files
- catalog.json
Source ID
H51-242DD09AA732A4BD35AF395A - dosing.json
Source ID
H51-9A85F7C9571C90D241370B5C - legacy-map.json
Source ID
H51-A0BB4ACE598704020876C82F - review-queue.json
Source ID
H51-624630441424E45E9D35CC42
- catalog.json
- Clinical release note
- Archived official label summary. Do not infer current U.S. commercial availability.
Source ID
H51-3E8238F4A7661C877D619C4F - Local label summary
- Available
- true
Source ID
H51-8A9D4540B351A04CAB080B96 - Status level
- archived
Source ID
H51-314017E629DC7B4685B068FA - Title
- Amphotericin B lipid complex injection (Abelcet)
Source ID
H51-9D5631E0782A8379D6372FA5 - Official url
- https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5587db37-f21a-4a39-a319-e1077032ced9 (opens in a new tab)
Source ID
H51-A797162BD70A08724F150EF2
Historical statement IDs and source locations
These IDs identify recovered source units. They are not evidence-qualified clinical claims.
| Historical ID | Original source location | Status |
|---|---|---|
H51-A7FB1A4E7E7C3F99809C25D8 | catalog.json/records/18/id | Historical; current review incomplete |
H51-92CF55DCCBBDE95194AD41B8 | catalog.json/records/18/legacy_title | Historical; current review incomplete |
H51-A8F876D24A7E2439DF6B8409 | catalog.json/records/18/generic_name | Historical; current review incomplete |
H51-3B96CBBB60B7818E2A6B9829 | catalog.json/records/18/class | Historical; current review incomplete |
H51-7ECB8B9D4F3BC65B90341C44 | catalog.json/records/18/subclass | Historical; current review incomplete |
H51-F298361D1D933A1BA830A704 | catalog.json/records/18/summary | Historical; current review incomplete |
H51-8A2011802254756741ACC57E | catalog.json/records/18/warnings/0 | Historical; current review incomplete |
H51-2E6A75FF0E0129FA43B60885 | catalog.json/records/18/stability_notes/0 | Historical; current review incomplete |
H51-E8F570B625C34AC7DBD5FC27 | catalog.json/records/18/populations/0 | Historical; current review incomplete |
H51-82D82F4D054B6662F7E37103 | catalog.json/records/18/evidence_tier | Historical; current review incomplete |
H51-21DCE240EACBDB25652CD0C5 | catalog.json/records/18/high_alert | Historical; current review incomplete |
H51-AD90EE3195AA202AD810A881 | catalog.json/records/18/hazardous | Historical; current review incomplete |
H51-10511BE5646C802F13AEF959 | catalog.json/records/18/status | Historical; current review incomplete |
H51-924D01E2CAA4B9800B564CC8 | catalog.json/records/18/reviewed | Historical; current review incomplete |
H51-6FA2D0BDC3960BCC57A81275 | catalog.json/records/18/version_added | Historical; current review incomplete |
H51-C64411F1B653FA57D67D499E | catalog.json/records/18/sources/0 | Historical; current review incomplete |
H51-D0F03061427545360F00DB73 | catalog.json/records/18/sources/0/label | Historical; current review incomplete |
H51-E1268AFE337858AF4F6072B3 | catalog.json/records/18/sources/0/url | Historical; current review incomplete |
H51-8F6B99AA92D0810646075F39 | catalog.json/records/18/sources/0/kind | Historical; current review incomplete |
H51-54C140C32017397F1A5FFAB9 | catalog.json/records/18/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-2C8AFA59064D518FB000DBB7 | catalog.json/records/18/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-0E02DA1B0B662F91E25E5932 | catalog.json/records/18/clinical_release_verification/level | Historical; current review incomplete |
H51-2DF99DD9DC3792BA2E4133FA | catalog.json/records/18/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-7C4AAFF9F0F365877E19C60F | catalog.json/records/18/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-07392533497650D1FEE612CE | catalog.json/records/18/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-71EFA860D7382726B9FA8620 | catalog.json/records/18/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-DBEE0C77E0EDD8F7CB959F7A | catalog.json/records/18/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-EFBBE5D46BCE0D40B1F6AFEC | catalog.json/records/18/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-ACA1643304109FDB0617E861 | catalog.json/records/18/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-1E210F495164AC40ABB75926 | catalog.json/records/18/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-D3F58E3F19074A808E11413C | catalog.json/records/18/clinical_release_verification/note | Historical; current review incomplete |
H51-F22E56369FF9D19C49A0AD0E | catalog.json/records/18/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-2ABCD5B81CE7B77CD5253DC3 | catalog.json/records/18/version_updated | Historical; current review incomplete |
H51-36C7059C1CC88CAB18788E10 | dailymed-label-snapshots-v5.1.json/records/3/id | Historical; current review incomplete |
H51-660FE994704DFA059782A09D | dailymed-label-snapshots-v5.1.json/records/3/catalog_name | Historical; current review incomplete |
H51-61D6F7C0BCB55A36C469E4C7 | dailymed-label-snapshots-v5.1.json/records/3/selection_status | Historical; current review incomplete |
H51-470506A5AEBDCE246A659EBB | dailymed-label-snapshots-v5.1.json/records/3/confidence | Historical; current review incomplete |
H51-58D717A9C68C3956EAC9B80B | dailymed-label-snapshots-v5.1.json/records/3/match_path | Historical; current review incomplete |
H51-0448C0A33BF6AA547293D990 | dailymed-label-snapshots-v5.1.json/records/3/brand_name | Historical; current review incomplete |
H51-79DB2FF48DC30868DF1917A3 | dailymed-label-snapshots-v5.1.json/records/3/label_title | Historical; current review incomplete |
H51-F5036E0AABE78CD5540AD86C | dailymed-label-snapshots-v5.1.json/records/3/labeler | Historical; current review incomplete |
H51-7C3020214D2E607CD185285B | dailymed-label-snapshots-v5.1.json/records/3/setid | Historical; current review incomplete |
H51-A6C8E0443A4D7BF8E5316D9C | dailymed-label-snapshots-v5.1.json/records/3/official_label_url | Historical; current review incomplete |
H51-489A1744006AEC16FC6EFA70 | dailymed-label-snapshots-v5.1.json/records/3/reviewed_on | Historical; current review incomplete |
H51-90174E98ACA033969F39EBCA | dailymed-label-snapshots-v5.1.json/records/3/route | Historical; current review incomplete |
H51-EEA76F086E65BB2032FE951F | dailymed-label-snapshots-v5.1.json/records/3/dosage_form | Historical; current review incomplete |
H51-9382DD1DBDBD9B8C1334ECF7 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/0 | Historical; current review incomplete |
H51-1791DAF86AA1389C92C78CF6 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/1 | Historical; current review incomplete |
H51-CEAAAFD78166F34B1DEE5824 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/2 | Historical; current review incomplete |
H51-313971DC5B7ADE709F8CD458 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/3 | Historical; current review incomplete |
H51-CA01410A822A265D4C506B08 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/4 | Historical; current review incomplete |
H51-CFCCF441CB3DF026955FFA92 | dailymed-label-snapshots-v5.1.json/records/3/dosage_administration_summary/5 | Historical; current review incomplete |
H51-0FA49A5271C1BAEFF1775CBF | dailymed-label-snapshots-v5.1.json/records/3/dosage_forms_strengths/0 | Historical; current review incomplete |
H51-75A1EC4458EA803B99AE544B | dailymed-label-snapshots-v5.1.json/records/3/dosage_forms_strengths/1 | Historical; current review incomplete |
H51-275AF18A73DA1322333B0765 | dailymed-label-snapshots-v5.1.json/records/3/mechanism_summary | Historical; current review incomplete |
H51-7BF06C49AC7965299FA8338B | dailymed-label-snapshots-v5.1.json/records/3/mechanism_source | Historical; current review incomplete |
H51-371795E482F52C18FA20876C | dailymed-label-snapshots-v5.1.json/records/3/scope_note | Historical; current review incomplete |
H51-BA8475592B9CE53FC1D566CF | dailymed-label-snapshots-v5.1.json/records/3/source_sections/0 | Historical; current review incomplete |
H51-A56EA815A14BD04C06A40DE8 | dailymed-label-snapshots-v5.1.json/records/3/source_sections/1 | Historical; current review incomplete |
H51-202D5E53CD010D386570FA99 | dailymed-label-snapshots-v5.1.json/records/3/source_sections/2 | Historical; current review incomplete |
H51-CD26F57513702D05EDA2765C | dailymed-label-snapshots-v5.1.json/records/3/retrieval_method | Historical; current review incomplete |
H51-227E3ACC81CD541B42FD54C3 | dailymed-label-snapshots-v5.1.json/records/3/label_status | Historical; current review incomplete |
H51-ED7F68A86334C1347584B6B4 | dailymed-label-snapshots-v5.1.json/records/3/disclaimer | Historical; current review incomplete |
H51-90B0768AB01DF3129F249DCB | dosing.json/records/18/id | Historical; current review incomplete |
H51-E63FEEAC5D81ED8D3EF92C78 | dosing.json/records/18/generic_name | Historical; current review incomplete |
H51-E9FAC943136742538DE3CF9A | dosing.json/records/18/coverage_status | Historical; current review incomplete |
H51-7C53850F5D6A9D9A54F7CA77 | dosing.json/records/18/package_insert/query_name | Historical; current review incomplete |
H51-67BB5A25C5B58326B0B54B73 | dosing.json/records/18/package_insert/preferred_setid | Historical; current review incomplete |
H51-A402DE3B3D0F807ECB72F1AB | dosing.json/records/18/package_insert/product_and_route_must_match | Historical; current review incomplete |
H51-C99A2879AC5751D9F48FB4E0 | dosing.json/records/18/package_insert/live_current_label_enabled | Historical; current review incomplete |
H51-00F8270F436E92E281CD30BF | dosing.json/records/18/package_insert/source_priority | Historical; current review incomplete |
H51-063246BF795D202C262106C5 | dosing.json/records/18/package_insert/direct_official_label_access_enabled | Historical; current review incomplete |
H51-A2331F5A062F402245BD9ADB | dosing.json/records/18/package_insert/outbound_server_request_required | Historical; current review incomplete |
H51-9556CE018D0129933FE69B91 | dosing.json/records/18/package_insert/local_summary_status | Historical; current review incomplete |
H51-BA288D116B89668079C12C6D | dosing.json/records/18/renal/classification | Historical; current review incomplete |
H51-541A534939A90E4CBE233840 | dosing.json/records/18/renal/summary | Historical; current review incomplete |
H51-3BEAFF7675A9268F076ADF30 | dosing.json/records/18/renal/method_note | Historical; current review incomplete |
H51-BB4512AACAC33D1B36A7488F | dosing.json/records/18/professional_sources/0 | Historical; current review incomplete |
H51-F470DAF97BB2C59AAE7C8027 | dosing.json/records/18/professional_sources/0/label | Historical; current review incomplete |
H51-AB8F569DD875F4BE29575673 | dosing.json/records/18/professional_sources/0/url | Historical; current review incomplete |
H51-C813C01C303F2CE8ECCDD74E | dosing.json/records/18/professional_sources/0/kind | Historical; current review incomplete |
H51-F795337BE666F79CC50853BB | dosing.json/records/18/professional_sources/1 | Historical; current review incomplete |
H51-F8D31534ABBB9D194D8D5A00 | dosing.json/records/18/professional_sources/1/label | Historical; current review incomplete |
H51-554D6A9E626342DEC343E8ED | dosing.json/records/18/professional_sources/1/url | Historical; current review incomplete |
H51-A483C245D6C9DEC6E5EF2C75 | dosing.json/records/18/professional_sources/1/kind | Historical; current review incomplete |
H51-0FF83EF5BE642D5FE121F928 | dosing.json/records/18/professional_sources/2 | Historical; current review incomplete |
H51-F29DF5FE91F574E3B9BC4F57 | dosing.json/records/18/professional_sources/2/label | Historical; current review incomplete |
H51-4DF150CFD92D8FB64673B70C | dosing.json/records/18/professional_sources/2/url | Historical; current review incomplete |
H51-3A9FAF53E89187D852EDB077 | dosing.json/records/18/professional_sources/2/kind | Historical; current review incomplete |
H51-ABF029FD2D271514E5ECBC8C | dosing.json/records/18/professional_sources/3 | Historical; current review incomplete |
H51-9F236747570C431CBB2421C9 | dosing.json/records/18/professional_sources/3/label | Historical; current review incomplete |
H51-72E559D39E403B81D08C58B8 | dosing.json/records/18/professional_sources/3/url | Historical; current review incomplete |
H51-15D697BF8F688799DB68FCA3 | dosing.json/records/18/professional_sources/3/kind | Historical; current review incomplete |
H51-C852F87A9B9EEDA168C2DE8B | dosing.json/records/18/clinical_review/locally_normalized | Historical; current review incomplete |
H51-DFBDD2DDB0439F82A8B0D67F | dosing.json/records/18/clinical_review/reviewed | Historical; current review incomplete |
H51-170AE8C618ECE976ED18C3BA | dosing.json/records/18/clinical_review/status | Historical; current review incomplete |
H51-6EC9156178F970379343490A | dosing.json/records/18/clinical_release_verification/audit_version | Historical; current review incomplete |
H51-CB8306F70376F58BF1101B39 | dosing.json/records/18/clinical_release_verification/audited_on | Historical; current review incomplete |
H51-3ECF328D9587B1AC79E9C75A | dosing.json/records/18/clinical_release_verification/level | Historical; current review incomplete |
H51-BFD39781747ACC8425308773 | dosing.json/records/18/clinical_release_verification/release_gate | Historical; current review incomplete |
H51-EAA8D51BA11D6CD788C561E5 | dosing.json/records/18/clinical_release_verification/exact_current_label_candidate | Historical; current review incomplete |
H51-121C2B375CF62DE2926CD092 | dosing.json/records/18/clinical_release_verification/selected_setid | Historical; current review incomplete |
H51-0B32AD068736F4AC9ECBA045 | dosing.json/records/18/clinical_release_verification/selected_label_title | Historical; current review incomplete |
H51-89432B8AB49310F85467E63B | dosing.json/records/18/clinical_release_verification/numeric_support_ratio | Historical; current review incomplete |
H51-F7C34D40C84F3DF25ED287C3 | dosing.json/records/18/clinical_release_verification/reference_url_count | Historical; current review incomplete |
H51-FED687ABAD70FDD259E229BE | dosing.json/records/18/clinical_release_verification/broken_reference_count | Historical; current review incomplete |
H51-986936927E7B0515AC189528 | dosing.json/records/18/clinical_release_verification/point_of_use_confirmation_required | Historical; current review incomplete |
H51-02AA55024F1D33B6CA5D1762 | dosing.json/records/18/clinical_release_verification/note | Historical; current review incomplete |
H51-84A179D07C05629730A877FE | dosing.json/records/18/clinical_release_verification/dailymed_search_url | Historical; current review incomplete |
H51-EC12E0680A64DB8540BDCAC9 | first-look-v5.1.json/records/18/id | Historical; current review incomplete |
H51-F87102A775E7537EF87C9CF2 | first-look-v5.1.json/records/18/generic_name | Historical; current review incomplete |
H51-F77D1FED80912ABA84C56459 | first-look-v5.1.json/records/18/class | Historical; current review incomplete |
H51-9919CC0EA6063D1DAE087B3F | first-look-v5.1.json/records/18/subclass | Historical; current review incomplete |
H51-6857F1B01FEA9C9CEA158A72 | first-look-v5.1.json/records/18/primary_uses/0 | Historical; current review incomplete |
H51-CE9F8A74E007CD5AF805CA2D | first-look-v5.1.json/records/18/mechanism | Historical; current review incomplete |
H51-0CC0CA1C5F1B6BE23DB83351 | first-look-v5.1.json/records/18/mechanism_level | Historical; current review incomplete |
H51-9847926636C3185EA09D4323 | first-look-v5.1.json/records/18/basic_dosing_orientation | Historical; current review incomplete |
H51-D97CA7E125DFB6319EF3FB34 | first-look-v5.1.json/records/18/administration_orientation | Historical; current review incomplete |
H51-8E4DF0E688EB36684E6A0BF5 | first-look-v5.1.json/records/18/renal_and_population_orientation | Historical; current review incomplete |
H51-EA2F8ACB7000E281FFD4B611 | first-look-v5.1.json/records/18/key_safety_orientation/0 | Historical; current review incomplete |
H51-CFBA4FD877830AD2C31B7C43 | first-look-v5.1.json/records/18/key_safety_orientation/1 | Historical; current review incomplete |
H51-83A235DA6F1B55D1CCD1E06B | first-look-v5.1.json/records/18/coverage_path | Historical; current review incomplete |
H51-DBB217CD959407724F005DDB | first-look-v5.1.json/records/18/coverage_path_label | Historical; current review incomplete |
H51-9A4D85364610E6AC52F637B9 | first-look-v5.1.json/records/18/official_label_url | Historical; current review incomplete |
H51-6111A58C3594140A080CA215 | first-look-v5.1.json/records/18/legacy_title | Historical; current review incomplete |
H51-E030FCB780DDE2766ADA0144 | first-look-v5.1.json/records/18/review_note | Historical; current review incomplete |
H51-35992005BFC3BB6CD69FC247 | first-look-v5.1.json/records/18/search_text | Historical; current review incomplete |
H51-B20466314D1D9390E32B44B7 | first-look-v5.1.json/records/18/official_search_url | Historical; current review incomplete |
H51-2A697EDC5813C054384B70E2 | first-look-v5.1.json/records/18/official_access_mode | Historical; current review incomplete |
H51-FA66CF6357944B58262F6C80 | first-look-v5.1.json/records/18/official_access_url | Historical; current review incomplete |
H51-3E6FD21A299FDEF61C9CEB54 | first-look-v5.1.json/records/18/official_search_query | Historical; current review incomplete |
H51-CF2EB4B0508B9BE1E00D0C35 | first-look-v5.1.json/records/18/official_access_reason | Historical; current review incomplete |
H51-2D87ED9E25C969EB38FC78DB | first-look-v5.1.json/records/18/label_snapshot_available | Historical; current review incomplete |
H51-380473B09C3B8F7B8E7232E0 | first-look-v5.1.json/records/18/label_snapshot_setid | Historical; current review incomplete |
H51-90248A6292A9AD095EA243D7 | local-label-summaries-v3.8.json/summaries/3/id | Historical; current review incomplete |
H51-5CA2B43CB1C41358095CF7D5 | local-label-summaries-v3.8.json/summaries/3/match_names/0 | Historical; current review incomplete |
H51-58CEA27E588461D820CB9A0F | local-label-summaries-v3.8.json/summaries/3/match_names/1 | Historical; current review incomplete |
H51-3BC888FB031D391F5CAB4677 | local-label-summaries-v3.8.json/summaries/3/label_title | Historical; current review incomplete |
H51-BB6F56BD85BF29A8873E7943 | local-label-summaries-v3.8.json/summaries/3/brand_names/0 | Historical; current review incomplete |
H51-12677563805B9A097FB88260 | local-label-summaries-v3.8.json/summaries/3/formulation | Historical; current review incomplete |
H51-064A1D577873392903450EA6 | local-label-summaries-v3.8.json/summaries/3/reconstitution | Historical; current review incomplete |
H51-733583780B706FE7C18B7D7E | local-label-summaries-v3.8.json/summaries/3/stock_concentration | Historical; current review incomplete |
H51-7001AA978E7CB27B30015602 | local-label-summaries-v3.8.json/summaries/3/diluents | Historical; current review incomplete |
H51-399A5734521A2E98875C6DE4 | local-label-summaries-v3.8.json/summaries/3/final_concentration | Historical; current review incomplete |
H51-0D1BC155561766A66CC80DC6 | local-label-summaries-v3.8.json/summaries/3/containers | Historical; current review incomplete |
H51-69AD63C46B2E1007B4086E47 | local-label-summaries-v3.8.json/summaries/3/infusion_time | Historical; current review incomplete |
H51-04FD3C1E2934902703FF2C3F | local-label-summaries-v3.8.json/summaries/3/fluid_restriction | Historical; current review incomplete |
H51-52600D3F3B6D1673325B337B | local-label-summaries-v3.8.json/summaries/3/stability | Historical; current review incomplete |
H51-BA22986FFAF1E62F0A4CE723 | local-label-summaries-v3.8.json/summaries/3/line_filter | Historical; current review incomplete |
H51-FB9B19480AE04DFADEB387E9 | local-label-summaries-v3.8.json/summaries/3/adult_applicability | Historical; current review incomplete |
H51-46BF988569EE626256CE46F1 | local-label-summaries-v3.8.json/summaries/3/pediatric_applicability | Historical; current review incomplete |
H51-CBF4CBA0023B3E2BCF7C8A2E | local-label-summaries-v3.8.json/summaries/3/neonatal_applicability | Historical; current review incomplete |
H51-62FB863182723CF6C81D34AF | local-label-summaries-v3.8.json/summaries/3/renal_dialysis | Historical; current review incomplete |
H51-85DFD2094142724598601013 | local-label-summaries-v3.8.json/summaries/3/key_warnings | Historical; current review incomplete |
H51-9999F97D41BAC263F8055E36 | local-label-summaries-v3.8.json/summaries/3/catalog_id | Historical; current review incomplete |
H51-BCE18EE1FEF1D717F07E7038 | local-label-summaries-v3.8.json/summaries/3/catalog_name | Historical; current review incomplete |
H51-FDE4B5FDA5DE0553E872040D | local-label-summaries-v3.8.json/summaries/3/review_date | Historical; current review incomplete |
H51-3A2D514FD790F9181F335C3C | local-label-summaries-v3.8.json/summaries/3/source_type | Historical; current review incomplete |
H51-C861DAECC03A91C8F0F7030F | local-label-summaries-v3.8.json/summaries/3/official_link_type | Historical; current review incomplete |
H51-97D56550D4D0D67D812B041B | local-label-summaries-v3.8.json/summaries/3/official_label_url | Historical; current review incomplete |
H51-E22A3B8AFEF5EAC6E3BF47C8 | local-label-summaries-v3.8.json/summaries/3/official_search_url | Historical; current review incomplete |
H51-9549858FF025276B52D34355 | local-label-summaries-v3.8.json/summaries/3/search_text | Historical; current review incomplete |
H51-859C06F2F9323385339E3361 | local-label-summaries-v3.8.json/summaries/3/label_status | Historical; current review incomplete |
H51-D80B1A520EB8A6BA425C61EF | local-label-summaries-v3.8.json/summaries/3/label_status_level | Historical; current review incomplete |
H51-28C966B299ECED4751EE739E | preparation-assessments-v3.8.json/18/id | Historical; current review incomplete |
H51-F6E957399907A7684A73DFDB | preparation-assessments-v3.8.json/18/name | Historical; current review incomplete |
H51-1AA6D47F6E2D5D4E3634CAD1 | preparation-assessments-v3.8.json/18/brands | Historical; current review incomplete |
H51-DF30314E33922F5701AE7B5F | preparation-assessments-v3.8.json/18/therapeutic_class | Historical; current review incomplete |
H51-98AAE8291BF8854E3A35CDF7 | preparation-assessments-v3.8.json/18/review_version | Historical; current review incomplete |
H51-0C630DCBDBB58EA83384D948 | preparation-assessments-v3.8.json/18/review_date | Historical; current review incomplete |
H51-800E0DF2777E30356D93EAEF | preparation-assessments-v3.8.json/18/release_status | Historical; current review incomplete |
H51-E5E2C967DC4B8940AB0D69DE | preparation-assessments-v3.8.json/18/market_status/status | Historical; current review incomplete |
H51-5E7C23B2D62BFBF406FD0442 | preparation-assessments-v3.8.json/18/market_status/basis | Historical; current review incomplete |
H51-78E5B557E28CF6A2657F2B9A | preparation-assessments-v3.8.json/18/ten_point_assessment/exact_formulation | Historical; current review incomplete |
H51-18353ADAEE276C2A4E2A26A7 | preparation-assessments-v3.8.json/18/ten_point_assessment/reconstitution_concentration | Historical; current review incomplete |
H51-B410DAF3B6F8E46DF82BEE97 | preparation-assessments-v3.8.json/18/ten_point_assessment/maximum_or_recommended_final_concentration | Historical; current review incomplete |
H51-D0D591D5F1878AE720F66AD8 | preparation-assessments-v3.8.json/18/ten_point_assessment/appropriate_standardized_containers | Historical; current review incomplete |
H51-244168F7ABAC1877C9E604D8 | preparation-assessments-v3.8.json/18/ten_point_assessment/adult_dosing_range | Historical; current review incomplete |
H51-447D68890C90A05B7F6A3D42 | preparation-assessments-v3.8.json/18/ten_point_assessment/pediatric_dosing_range | Historical; current review incomplete |
H51-329499090578E391383E8CDA | preparation-assessments-v3.8.json/18/ten_point_assessment/neonatal_dosing_range | Historical; current review incomplete |
H51-9F1AA15BBB13BD6BD55D082D | preparation-assessments-v3.8.json/18/ten_point_assessment/infusion_time | Historical; current review incomplete |
H51-4686AC7D68EFBD5DBF457953 | preparation-assessments-v3.8.json/18/ten_point_assessment/fluid_restriction_alternatives | Historical; current review incomplete |
H51-65C68AE7EBEFA90FC131DEE1 | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/setid | Historical; current review incomplete |
H51-AA93C56DB61C6865198B332A | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/title | Historical; current review incomplete |
H51-5A65170093C2171828474562 | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/published_date | Historical; current review incomplete |
H51-5EC275AC254441B51AD369C4 | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/manufacturer | Historical; current review incomplete |
H51-4BB4F979C30F9256FDF10A15 | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/routes/0 | Historical; current review incomplete |
H51-774B4857B44ECAE94B147AA5 | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/match_confidence | Historical; current review incomplete |
H51-47A964FF7189EC8EDA07B95C | preparation-assessments-v3.8.json/18/ten_point_assessment/current_manufacturer_labeling/url | Historical; current review incomplete |
H51-571BF02A3A1E6F39D82FDA5E | preparation-assessments-v3.8.json/18/field_provenance/exact_formulation/primary | Historical; current review incomplete |
H51-C75D6849FF2D6B892DEC6C4C | preparation-assessments-v3.8.json/18/field_provenance/reconstitution_concentration/primary | Historical; current review incomplete |
H51-7DC9D212C1DDEA51065BC172 | preparation-assessments-v3.8.json/18/field_provenance/maximum_or_recommended_final_concentration/primary | Historical; current review incomplete |
H51-CD8B8A75BD78EF97D32FA9F5 | preparation-assessments-v3.8.json/18/field_provenance/appropriate_standardized_containers/primary | Historical; current review incomplete |
H51-0BB7C61441407B4D12050CC7 | preparation-assessments-v3.8.json/18/field_provenance/adult_dosing_range/primary | Historical; current review incomplete |
H51-C4CF55AEF7424D98F3930BC6 | preparation-assessments-v3.8.json/18/field_provenance/pediatric_dosing_range/primary | Historical; current review incomplete |
H51-B5E9BF5576A6B5267CD2A8F1 | preparation-assessments-v3.8.json/18/field_provenance/neonatal_dosing_range/primary | Historical; current review incomplete |
H51-2C4DABDD92C4995D6512809E | preparation-assessments-v3.8.json/18/field_provenance/infusion_time/primary | Historical; current review incomplete |
H51-D1D8882A7163FC633E0A421B | preparation-assessments-v3.8.json/18/field_provenance/fluid_restriction_alternatives/primary | Historical; current review incomplete |
H51-C94FC58AD7C9F5C69377F789 | preparation-assessments-v3.8.json/18/field_provenance/current_manufacturer_labeling/primary | Historical; current review incomplete |
H51-9D4C67D48C35B2FE994B805C | preparation-assessments-v3.8.json/18/population_applicability/adult/applicability | Historical; current review incomplete |
H51-48656EE0CB706D2703B3F42D | preparation-assessments-v3.8.json/18/population_applicability/adult/guide_generation_allowed | Historical; current review incomplete |
H51-4C0674C5277041B23DE7EA63 | preparation-assessments-v3.8.json/18/population_applicability/pediatric/applicability | Historical; current review incomplete |
H51-0B10EFF60972A53FB1DA3B51 | preparation-assessments-v3.8.json/18/population_applicability/pediatric/guide_generation_allowed | Historical; current review incomplete |
H51-27438BFBDD5CD4134EABC4CA | preparation-assessments-v3.8.json/18/population_applicability/neonatal/applicability | Historical; current review incomplete |
H51-00B803499CB4ECB38365E93B | preparation-assessments-v3.8.json/18/population_applicability/neonatal/guide_generation_allowed | Historical; current review incomplete |
H51-43096ED84E98E2B5DCD858C2 | preparation-assessments-v3.8.json/18/route_presence/structured_dilution | Historical; current review incomplete |
H51-6C5E4782EAD242D415A6D2F5 | preparation-assessments-v3.8.json/18/route_presence/iv_push | Historical; current review incomplete |
H51-847E25C731ADE5C700F29895 | preparation-assessments-v3.8.json/18/route_presence/continuous_infusion | Historical; current review incomplete |
H51-692FC63755C74B55AED3F9F2 | preparation-assessments-v3.8.json/18/route_presence/pediatric_source | Historical; current review incomplete |
H51-D484101240D2D6F65F4FFD24 | preparation-assessments-v3.8.json/18/route_presence/neonatal_source | Historical; current review incomplete |
H51-20483F0583EFF0A0A2BC7754 | preparation-assessments-v3.8.json/18/legacy_reference/status | Historical; current review incomplete |
H51-C5F654FEDD852FAD9592118B | preparation-assessments-v3.8.json/18/label_resolution/status | Historical; current review incomplete |
H51-7F18C8B1D640D2AC61073294 | preparation-assessments-v3.8.json/18/label_resolution/existing_setids/0 | Historical; current review incomplete |
H51-7EBF9B38D3C93B2892B70EBF | preparation-assessments-v3.8.json/18/label_resolution/official_url | Historical; current review incomplete |
H51-CF969872D661050E5AAA3D90 | preparation-assessments-v3.8.json/18/label_resolution/review_date | Historical; current review incomplete |
H51-242DD09AA732A4BD35AF395A | preparation-assessments-v3.8.json/18/source_files/0 | Historical; current review incomplete |
H51-9A85F7C9571C90D241370B5C | preparation-assessments-v3.8.json/18/source_files/1 | Historical; current review incomplete |
H51-A0BB4ACE598704020876C82F | preparation-assessments-v3.8.json/18/source_files/2 | Historical; current review incomplete |
H51-624630441424E45E9D35CC42 | preparation-assessments-v3.8.json/18/source_files/3 | Historical; current review incomplete |
H51-3E8238F4A7661C877D619C4F | preparation-assessments-v3.8.json/18/clinical_release_note | Historical; current review incomplete |
H51-8A9D4540B351A04CAB080B96 | preparation-assessments-v3.8.json/18/local_label_summary/available | Historical; current review incomplete |
H51-314017E629DC7B4685B068FA | preparation-assessments-v3.8.json/18/local_label_summary/status_level | Historical; current review incomplete |
H51-9D5631E0782A8379D6372FA5 | preparation-assessments-v3.8.json/18/local_label_summary/title | Historical; current review incomplete |
H51-A797162BD70A08724F150EF2 | preparation-assessments-v3.8.json/18/local_label_summary/official_url | Historical; current review incomplete |
Open the original GlobalRPh site monograph (historical; not revalidated) (opens in a new tab)